Ranking Alexa Global: # 13,689,683
Server:Apache...
The main IP address: 199.34.228.59,Your server United States,San Francisco ISP:Weebly Inc. TLD:com CountryCode:US
The description :oxfordbiotherapeutics...
This report updates in 06-Nov-2018
Created Date: | 2008-08-19 |
Changed Date: | 2014-09-05 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host oxfordbiotherapeutics.com. Currently, hosted in United States and its service provider is Weebly Inc. .
Latitude: | 37.775699615479 |
Longitude: | -122.39520263672 |
Country: | United States (US) |
City: | San Francisco |
Region: | California |
ISP: | Weebly Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 7979 |
X-Host: | pages53.sf2p.intern.weebly.net |
Content-Encoding: | gzip |
Set-Cookie: | is_mobile=0; path=/; domain=www.oxfordbiotherapeutics.com, language=en; expires=Mon, 19-Nov-2018 17:12:36 GMT; Max-Age=1209600; path=/, gdpr-kb=1; expires=Thu, 02-Nov-2028 17:12:36 GMT; Max-Age=315360000; path=/ |
Vary: | X-W-SSL,Accept-Encoding,User-Agent |
Keep-Alive: | timeout=10, max=72 |
Server: | Apache |
Connection: | Keep-Alive |
ETag: | W/"0c87304bdea3979a08d8d0ddd7d0790a-gzip" |
X-UA-Compatible: | IE=edge,chrome=1 |
Cache-Control: | private |
Date: | Mon, 05 Nov 2018 17:12:36 GMT |
Content-Type: | text/html; charset=UTF-8 |
soa: | ns0.phase8.net. support.phase8.net. 2018020601 28800 3600 604800 3600 |
txt: | "google-site-verification=r2fIP3V5ZhnVMmU8oXugbT_15aGkOPMH1ItzI-5Wbhw" "MS=ms83086230" "v=spf1 include:spf.protection.outlook.com -all" |
ns: | ns1.phase8.net. ns2.phase8.net. ns0.phase8.net. |
ipv4: | IP:199.34.228.59 ASN:27647 OWNER:WEEBLY - Weebly, Inc., US Country:US |
mx: | MX preference = 10, mail exchanger = oxfordbiotherapeutics-com.mail.protection.outlook.com. |
about company overview senior leadership > management board of directors investors offices & labs careers io discovery immune checkpoint targets io antibody engineering pipelines news contact harnessing immune cells to cure cancer redefining the cancer-immune synapse for novel immune checkpoint mechanisms novel io discoveries pipelines immunotherapies for cancer oxford biotherapeutics (obt) is a clinical stage oncology company committed to the discovery and development of novel therapies for various cancer types. obt's approach, based on our proprietary immune-oncology and antibody-drug conjugate pipelines, is to re-engage and recruit the body's immune system to attack cancer cells. we are therefore able to provide targeted treatment strategies to patients most in need, including those who have failed to respond to conventional treatments. our first therapy, a drug for relapsed/refractory acute myeloid leukemia (aml), entered ph i testing in europe in 2012 in collaboration with the menarini group . to help bring about this much awaited transformation in the cancer therapy landscape, we have built one of the world’s largest integrated oncology immune cell surface protein libraries. this, together with our dedicated team of international immuno-oncology experts and our broad clinical alliances, have led to our discovery of multiple never-before identified cancer-immune cell targets , and the subsequent development of therapies based on these findings. overview fully funded clinical adc/c pipeline portfolio approach – up to five programs de-risked to ph ii/ poc through partnership broader innovative io pipeline critical discovery: major novel immune escape mechanism discovery of novel io receptors & ligands 300+ patents 100 granted milestones 1st adcc monoclonal antibody in aml men1112 - phi ongoing 2nd adc in tnbc, dlbcl & other men1309 - phi initiated upto €800 million investment from menarini ltd. clincal testing of upto 5 mabs obt retains us & japanese rights io pipeline multiple programs in pre-clinical development global headquarters 94a innovation drive milton park abingdon ox14 4rz uk +44 (0) 1235 861770 contact us us operations san jose biocenter 5941 optical court san jose, ca 95138 usa +1-408-960-7461 contact us privacy policy legal notice site map © 2017 oxford biotherapeutics all rights reserved about company overview senior leadership > management board of directors investors offices & labs careers io discovery immune checkpoint targets io antibody engineering pipelines news contact
http://www.oxfordbiotherapeutics.com/board-of-directors.html
http://www.oxfordbiotherapeutics.com/iodiscovery-antibody-engineering.html
http://www.oxfordbiotherapeutics.com/iodiscovery-immune-checkpoint-targets.html
http://www.oxfordbiotherapeutics.com/investors.html
http://www.oxfordbiotherapeutics.com/management.html
http://www.oxfordbiotherapeutics.com/contact.html
http://www.oxfordbiotherapeutics.com/news.html
http://www.oxfordbiotherapeutics.com/offices-and-labs.html
http://www.oxfordbiotherapeutics.com/pipelines.html
http://www.oxfordbiotherapeutics.com/privacy-policy.html
http://www.oxfordbiotherapeutics.com/legal-notice.html
http://www.oxfordbiotherapeutics.com/careers.html
http://www.oxfordbiotherapeutics.com/company-overview.html
http://www.oxfordbiotherapeutics.com/site-map.html
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: OXFORDBIOTHERAPEUTICS.COM
Registry Domain ID: 1514892813_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.register.it
Registrar URL: http://www.register.it
Updated Date: 2014-09-05T15:00:17Z
Creation Date: 2008-08-19T13:44:10Z
Registry Expiry Date: 2024-08-19T13:44:10Z
Registrar: Register.it SPA
Registrar IANA ID: 168
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +39.5520021555
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.PHASE8.NET
Name Server: NS1.PHASE8.NET
Name Server: NS2.PHASE8.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-11-19T10:14:07Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR Register.it SPA
SERVERS
SERVER com.whois-servers.net
ARGS domain =oxfordbiotherapeutics.com
PORT 43
TYPE domain
DOMAIN
NAME oxfordbiotherapeutics.com
CHANGED 2014-09-05
CREATED 2008-08-19
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
NSERVER
NS0.PHASE8.NET 81.88.63.114
NS1.PHASE8.NET 85.233.160.68
NS2.PHASE8.NET 85.233.164.62
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .